Corvallis, OR, United States of America

William Bisson


 

Average Co-Inventor Count = 7.5

ph-index = 1


Location History:

  • Genève, CH (2016)
  • Corvallis, OR (US) (2017)

Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: William Bisson: Innovator in Cancer Treatment

Introduction

William Bisson is a notable inventor based in Corvallis, OR (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a focus on developing pharmaceutical compositions, Bisson's work aims to provide new therapeutic options for patients battling cancer.

Latest Patents

William Bisson holds 2 patents related to cancer treatment. His latest patents include "2-acylaminothiazoles for the treatment of cancer," which involves inhibitors of the oncogenic protein kinase ALK. This invention describes pharmaceutical compositions that utilize these compounds for the preparation of medicaments specifically aimed at treating cancer. Another significant patent is for "Alpha-carbolines for the treatment of cancer," which also focuses on inhibitors of the oncogenic protein kinase ALK and outlines key intermediates for their synthesis.

Career Highlights

Throughout his career, Bisson has worked with esteemed institutions such as Università degli Studi di Milano-Bicocca and Université de Genève. His research has been pivotal in advancing the understanding and treatment of cancer, showcasing his dedication to improving patient outcomes through innovative solutions.

Collaborations

William Bisson has collaborated with notable colleagues in his field, including Carlo Gambacorti-Passerini and Luca Mologni. These partnerships have further enriched his research and contributed to the development of effective cancer treatments.

Conclusion

William Bisson's contributions to cancer treatment through his patents and collaborations highlight his commitment to innovation in the medical field. His work continues to inspire advancements in therapeutic options for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…